Search
Tractament antiviral de l'hepatitis C crònica a l'any 2019, 2020 i 2021: informe d'avaluació de resultats
(2022-02)
Minority diseases pose a major challenge to the health system, as they often have a genetic origin, can affect many organs, be serious, pose a vital threat, or be chronically debilitating. Their diagnosis is difficult, ...
Luteci (177Lu) oxodotreotida per al tractament de tumors neuroendocrins gastroenteropancreàtics positius al receptor de somatostatina, ben diferenciats, progressius i irresecables o metastàtics
(2020-07-07)
Neuroendocrine tumors (TNEs) are defined as those neoplasms with a predominantly neuroendocrine cell differentiation, which can arise in most organs, although most are of gastrointestinal or pancreatic origin (≈65%). The ...
Tractament de malalties minoritàries amb medicaments d'autorització individual a l'any 2019: informe d'avaluació de resultats
(2020)
Minority diseases pose a major challenge to the health system, as they are often of genetic origin and can affect many organs, be serious, pose a threat to life, or be chronically debilitating. Their diagnosis is difficult, ...
Trastuzumab per al tractament del càncer gàstric o d'unió gastroesofàgica metàstasic HER2+: informe d'avaluació de resultats
(2018)
Trastuzumab is a humanized monoclonal antibody against human epidermal growth factor (HER2) receptor 2, which in 2010 was approved by the European Agency of the
Medication (EMA) for the treatment of gastric cancer or ...
Tractament farmacològic de la malaltia d’Alzheimer: informe del Registre de Tractament Farmacològic de la Malaltia d’Alzheimer a l’any 2019
(2020)
Alzheimer’s disease (AD) is a progressive, irreversible neurodegenerative disorder that is usually slow but sustained over time. AD is the most common cause of dementia (69%). Its prevalence is 5.1% and increases exponentially ...
Tractament farmacològic de la malaltia d’Alzheimer: informe del Registre de Tractament Farmacològic de la Malaltia d’Alzheimer a l’any 2018
(2019)
Alzheimer's disease (MA) is a progressive and irreversible neurodegenerative disorder usually a slow but sustained development over time. MA is the most frequent cause of dementia (69%). Its prevalence is 5.1% and increases ...
Tractament del CPNM metastàtic EFGR positiu amb inhibidors d’ITK en primera línia: informe d'avaluació de resultats
(2021)
Lung cancer (LC) is one of the most frequently diagnosed cancers worldwide. In Spain, the estimated incidence of new cases of LC for 2019 was 29,503 cases. LC remains the leading cause of cancer death in Spain in both ...